Resumo (PT):
Recent studies have shown that neurohumoral agents such as angiotensin
II (Ang II), endothelin-1 (ET-1) and β-adrenergic stimulation acutely decrease
myocardial stiffness. Concerning the latter, its effect is dependent
on PKA, PKC and NA+/H+ exchanger. It was also demonstrated that the
effect promoted by Ang II and ET-1 is, among others, dependent on the
integrity of the endocardial endothelium (EE) and the release of nitric oxide
and prostaglandins. The present study investigated the role of EE and
prostaglandins on β-adrenergic induced diastolic distensibility. Effects of
increasing concentrations of isoproterenol (ISO; 10-10 to 10-5M) were
evaluated in isolated right papillary muscles from male New Zealand
White rabbits (Krebs-Ringer: 1.8mM CaCl2, 35°C) in the presence of:
(i) intact EE (n=11); (ii) damaged EE (Triton X-100, 0.5%, 1s, n=7)
and (iii) Indomethacin (INDO; cyclooxigenase inhibitor, 10-5M; n=7).
Reported parameters include: active tension (AT; mN/mm2), maximum
velocities of tension rise and decline (dT/dtmax and dT/dtmin, respectively;
mN/mm2/s), passive tension (PT; mN/mm2) and muscle length (L;
L/Lmax). Only significant results (mean±SEM, p<0.05) are given, expressed
as%change frombaseline.ISO induced concentration-dependent
positive inotropic and lusitropic effects maximal at 10-5M, which increased
93.1±15.7% AT, 286.6±32.9% dT/dtmax, and 166.1±23% dT/dtmin. The same concentration of ISO induced a significant increase
of the muscular length from Lmax to 1.018±0.005 L/Lmax, which corresponds
to a 37.5±7.6% decrease of PT and represents a significant
decrease of myocardial stiffness. The diastolic myocardial effects of
ISO were maintained after removing EE and in the presence of INDO.
This study demonstrated that β-adrenergic stimulation acutely increases
myocardial distensibility even after EE removal and is independent of
prostaglandin release in contrast to what happened with other neurohumoral
agents. This might have important pathophysiologic implications in heart failure as well as several other pathological conditions where EE dysfunction occurs.
Language:
English
Type (Professor's evaluation):
Scientific
Notes:
Heart Failure 2007, published in journal, European Journal of Heart Failure Supplements. 2007; 6(Suppl. 1):38.